Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Investment in real estate:    
Land $ 116,123 $ 95,381
Building 793,559 693,533
Site improvements 13,268 9,912
Tenant improvements 46,965 33,909
Acquired lease intangible assets 91,465 72,794
Investment in real estate, Total 1,061,380 905,529
Less: accumulated depreciation and amortization (83,893) (56,503)
Investment in real estate, net 977,487 849,026
Cash and cash equivalents 2,052 2,765
Restricted cash 5,210 4,420
Tenant receivables 6,702 4,957
Due from related parties 121 50
Escrow deposits 3,792 3,417
Deferred assets 18,928 14,512
Derivative asset   2,194
Goodwill 5,903  
Other assets 5,356 3,593
Total assets 1,025,551 884,934
Liabilities:    
Credit Facility, net of unamortized debt issuance costs of $3,875 and $3,832 at September 30, 2020 and December 31, 2019, respectively 454,325 347,518
Notes payable, net of unamortized debt issuance costs of $898 and $667 at September 30, 2020 and December 31, 2019, respectively 65,060 38,650
Accounts payable and accrued expenses 8,329 5,069
Dividends payable 11,843 11,091
Security deposits and other 5,571 6,351
Due to related party   1,648
Derivative liability 19,505 8,685
Other liability 3,090 2,405
Acquired lease intangible liability, net 8,621 3,164
Total liabilities 576,344 424,581
Equity:    
Preferred stock, $0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at September 30, 2020 and December 31, 2019, respectively (liquidation preference of $77,625 at September 30, 2020 and December 31, 2019, respectively) 74,959 74,959
Common stock, $0.001 par value, 500,000 shares authorized; 48,188 shares and 43,806 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 48 44
Additional paid-in capital 487,114 433,330
Accumulated deficit (107,943) (71,389)
Accumulated other comprehensive loss (19,651) (6,674)
Total Global Medical REIT Inc. stockholders' equity 434,527 430,270
Noncontrolling interest 14,680 30,083
Total equity 449,207 460,353
Total liabilities and equity $ 1,025,551 $ 884,934